Let’s Talk About Kidneys
Polycystic kidney disease (PKD) is a genetic disorder that can lead to chronic kidney disease, hypertension, and kidney failure. Affecting between 500,000 and 600,000 Americans, treatment targets symptom management with diet, medications, and, if needed, dialysis or a kidney transplant.
info_outlineLet’s Talk About Kidneys
Polycystic Kidney Disease (PKD) affects about 600,000 people in the United States, according to the PKD Foundation. It is one of the most common genetic kidney disorders, yet many people don’t even know they have it until later in life. Today, we’ll break down what PKD is, how it’s diagnosed, and how people can live well with it.
info_outlineLet’s Talk About Kidneys
In this episode of Let’s Talk About Kidneys, Dr. Jayasree Grandhi of Dallas Nephrology Associates breaks down kidney stones—what they are, what causes them, and how to prevent and treat them. Affecting up to 1 in 5 men and 1 in 10 women, kidney stones are common but manageable with the right care.
info_outlineLet’s Talk About Kidneys
Chronic Kidney Disease (CKD) is a condition that affects how the kidneys work over time. For women with CKD who are planning to have a family, there are important factors to consider to ensure the best possible outcomes. Can I have a baby if I have CKD?
info_outlineLet’s Talk About Kidneys
In this episode of Let's Talk About Kidneys, Dr. Lauren McDonald, a nephrologist with Dallas Nephrology Associates, discusses the diagnosis, staging, and common tests for patients with chronic kidney disease (CKD). Dr. McDonald explains how kidney disease is diagnosed, common symptoms, and some of the key tests, including BUN, creatinine, GFR, hemoglobin A1C, kidney biopsies, and more. She also discusses the importance of being your own healthcare advocate, family histories, how to maintain health records, and the importance of monitoring your diabetes, and...
info_outlineLet’s Talk About Kidneys
This episode of Let's Talk About Kidneys, Dr. Saim, a nephrologist with Dallas Nephrology Associates, discusses what is new in kidney transplant. The podcast discusses advancements in kidney transplantation, focusing on the benefits and risks of living and deceased donor transplant. Dr. Saim highlights that over 25,000 transplants were performed last year, with nearly 7,000 from living donors. Living donor transplants offer better survival rates and shorter waiting time. The waiting list has nearly 100,000 patients, with blood group O having the longest wait. ...
info_outlineLet’s Talk About Kidneys
Let's Talk About Kidneys Dialysis Patients and Their Diet In this episode of Let’s Talk About Kidneys, Dr. Rao, a nephrologist at Dallas Nephrology Associates, discusses the importance of diet for all dialysis patients. She emphasizes the need for dietary modifications even before dialysis, focusing on reducing salt intake, managing potassium and phosphorus levels, and maintaining adequate protein consumption. Introduction Dr. Rao shares her background, mentioning that she joined Dallas Nephrology Associates fifteen years ago and sees patients mostly in Mesquite, Sunnyvale, and...
info_outlineLet’s Talk About Kidneys
In this episode of the Let’s Talk About Kidneys podcast, Dr. Roberto Collazo addresses the development of new treatments for kidney disease that are essential for slowing disease progression, improving patient outcomes, and preventing kidney failure. Throughout his discussion, he will examine various therapeutic options currently available, as well as those expected in the future. What types of treatments have there been in the past for patients with Chronic Kidney Disease (CKD)? Dr. Collazo addressed the medications available during the 1990s and early 2000s. He also discussed newly...
info_outlineLet’s Talk About Kidneys
In this episode of the Let’s Talk About Kidneys podcast, Dallas Nephrology Associates Dietitian, Nadiya Lakhani, RDN, CSR, LD, FNKF, explains why weight management is important to the general population and how it affects the kidneys. How does weight affect the kidneys? When the body carries more weight than it can handle, it increases the demand on the kidneys to hyper filtrate. In other words, it forces your kidneys to work harder, which will eventually cause them to be overworked. On the flip side, unintentional weight loss increases the risk of that person having increased...
info_outlineLet’s Talk About Kidneys
In this episode of the Let’s Talk About Kidneys podcast, Dr. Muhammad Qureshi talks about the benefits of a kidney transplant, why it’s a good choice after kidney failure, and what the process looks like before, during and after. Why should a CKD patient consider a kidney transplant? Dr. Qureshi talks about the fact that there are both mortality and morbidity benefits of a kidney transplant. In other words, not only do you live longer, but you live better. Who qualifies for a kidney transplant? Anyone who has a kidney function less than 20% or someone who has already...
info_outlineIn this episode of the Let’s Talk About Kidneys podcast, Dr. Roberto Collazo addresses the development of new treatments for kidney disease that are essential for slowing disease progression, improving patient outcomes, and preventing kidney failure. Throughout his discussion, he will examine various therapeutic options currently available, as well as those expected in the future.
What types of treatments have there been in the past for patients with Chronic Kidney Disease (CKD)?
Dr. Collazo addressed the medications available during the 1990s and early 2000s. He also discussed newly introduced medications aimed at slowing the progression of kidney disease and enhancing patient outcomes.
What are the new types of treatments?
Dr. Collazo discussed several new treatment therapies currently available, which have led to positive outcomes. These treatments include:
· Angiotensin-converting enzyme (ACE) Inhibitors / Angiotensin receptor blockers (ARBs)
· Flozins (also known as sodium-glucose co-transporter 2 or SGLT-2 Inhibitors)
· Non-steroidal mineralocorticoid receptor antagonists (nsMRAs)
· Glucagon-like peptide-1 agonist (GLP-1)
What research has been completed regarding the benefits in treatment of other conditions related to kidney disease?
Dr. Collazo addressed the recent statement issued by the American Heart Association, which acknowledges a new syndrome known as cardio-kidney-metabolic (CKM) syndrome. Cardio-kidney-metabolic (CKM) syndrome is a health condition that impacts the heart, kidneys, and metabolism.
Would you provide me with an example of one of your patients who have benefitted from one of these new treatment therapies?
Dr. Collazo spoke about a recent patient who received a diagnosis of both hypertension and heart disease. He also discussed the measures undertaken to address the patient's condition using new therapies.
How can kidney patients get involved?
Dr. Collazo emphasizes the significance of cultivating a relationship with one's primary care physician and nephrologist. Patients are encouraged to ask about new therapies that may assist in managing or slowing the progression of their condition during their appointments with their physician.
Dr. Collazo concludes the podcast by noting that advancements in nephrology are progressing. New medications and updated therapies are becoming available that will assist in preventing patients from needing dialysis or transplantation.